| 摘要 |
<p>The present invention relates to ophthalmic compositions for the treatment of ocular hypertension and glaucoma, comprising a hypotonic solution of 0.1 to 0.2 % (w/w) of xanthan gum and 0.5 to 5 % (w/w) of a topical carbonic anhydrase inhibitor or an ophthalmologically acceptable salt thereof.</p> |
